About us Contacts Drug interactions: 390 212
Drug search by name

Edecrin Sodium and Lithium Syrup and Oral Solution

Determining the interaction of Edecrin Sodium and Lithium Syrup and Oral Solution and the possibility of their joint administration.

Check result:
Edecrin Sodium <> Lithium Syrup and Oral Solution
Relevance: 12.05.2023 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Ask your doctor before using ethacrynic acid together with lithium. Using ethacrynic acid together with lithium may increase the effects of lithium. This may cause diarrhea, vomiting, drowsiness, tremor, thirst, increased urination, lack of coordination, or muscle weakness. You may need a dose adjustment or special test to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

GENERALLY AVOID: Loop diuretics may increase serum lithium levels and potentiate the risk of lithium toxicity. The exact mechanism is unknown but may be related to the sodium loss induced by loop diuresis, which produces a compensatory increase in proximal tubular reabsorption of sodium along with lithium. Although a few studies using furosemide found no significant effect on serum lithium levels for up to 12 weeks of concomitant use, serious lithium toxicity has been reported, particularly in elderly patients. In a population-based case-control study of 10,615 patients older than 65 years who were receiving continuous lithium therapy for a total of 26,866 patient-years, 413 (4%) case patients were identified over a 10-year period who had at least one hospital admission for lithium toxicity. After adjustment for potential confounders, any exposure to a loop diuretic within the preceding 28 days of the episode was associated with a 1.7 relative risk of hospitalization for lithium toxicity compared to matched controls, and new exposure to a loop diuretic (defined as no other use of a loop diuretic in the preceding 365 days) was associated with a relative risk of 5.5. Overall, approximately 2.4% of all hospitalizations for lithium toxicity in this elderly cohort could be attributed to new use of a loop diuretic. There have also been individual case reports of patients developing lithium toxicity shortly after initiation of a loop diuretic. The risk for lithium toxicity may be further increased during concomitant sodium restriction.

MANAGEMENT: Loop diuretics should generally not be prescribed to patients receiving lithium unless close monitoring of serum lithium levels and electrolytes can be rendered. Lithium dose reductions may be required. Patients should be advised to notify their physician if they experience potential signs and symptoms of lithium toxicity such as drowsiness, dizziness, muscle weakness, vomiting, diarrhea, thirst, polyuria, tinnitus, tremor, ataxia, and blurred vision.

References
  • Finley PR, Warner MD, Peabody CA "Clinical relevance of drug interactions with lithium." Clin Pharmacokinet 29 (1995): 172-91
  • MacNeil S, Hanson-Nortey E, Paschalis C, et al "Diuretics during lithium therapy." Lancet 06/07/75 (1975): 1295-6
  • Bennett WM "Drug interactions and consequences of sodium restriction." Am J Clin Nutr 65 (1997): S678-81
  • Aronson JK, Reynolds DJM "ABC of monitoring drug therapy. Lithium." Br Med J 305 (1992): 1273-6
  • Jefferson JW, Kalin NH "Serum lithium levels and long-term diuretic use." JAMA 241 (1979): 1134-6
  • "Product Information. Eskalith (lithium)." SmithKline Beecham, Philadelphia, PA.
  • Juurlink DN, Mamdani MM, Kopp A, Rochon PA, Shulman KI, Redelmeier DA "Drug-induced lithium toxicity in the elderly: a population-based study." J Am Geriatr Soc 52 (2004): 794-8
  • Atherton JC, Green R, Hughes S, et al "Lithium clearance in man: effects of dietary salt intake, acute changes in extracellular fluid volume, amiloride and frusemide." Clin Sci 73 (1987): 645-51
  • Huang LG "Lithium intoxication with coadministration of a loop-diuretic." J Clin Psychopharmacol 10 (1990): 228
  • Crabtree BL, Mack JE, Johnson CD, Amyx BC "Comparison of the effects of hydrochlorothiazide and furosemide on lithium disposition." Am J Psychiatry 148 (1991): 1060-3
  • Beutler JJ, Boer WH, Koomans HA, Dorhout Mees EJ "Comparative study of the effects of furosemide, ethacrynic acid and bumetanide on the lithium clearance and diluting segment reabsorption in humans." J Pharmacol Exp Ther 260 (1992): 768-72
  • Kerry RJ, Ludlow JM, Owen G "Diuretics are dangerous with lithium." Br Med J 281 (1980): 371
  • Hurtig HI, Dyson WL "Lithium toxicity enhanced by diuresis." N Engl J Med 290 (1974): 748-9
Edecrin Sodium

Generic Name: ethacrynic acid

Brand name: Sodium Edecrin, Edecrin, Edecrin Sodium

Synonyms: Sodium Edecrin

Lithium Syrup and Oral Solution

Generic Name: lithium

Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR

Synonyms: Lithium

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Interaction with food and lifestyle